METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14694135

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention describes an association between genetic polymorphisms in the FAM13A1 (family with sequence similarity 13, member A1) gene and a predisposition to prolongation of the QT interval, and provides related methods for the prediction of such a predisposition, the administration of QT interval-prolonging compounds to individuals having such a predisposition, and determining whether a compound is capable of inducing QT prolongation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VANDA PHARMACEUTICALS INC2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lavedan, Christian Potomac, US 44 72
Licamele, Louis Potomac, US 17 35
Volpi, Simona Derwood, US 25 42

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation